Nasdaq Itos News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ITeos Therapeutics (NASDAQ:ITOS – Get Free Report) and Caribou Biosciences (NASDAQ:CRBU – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, earnings, valuation, risk and analyst recommendations. Profitability This table compares iTeos Therapeutics and […]

ITeos Therapeutics (NASDAQ:ITOS – Get Free Report) and Inhibrx (NASDAQ:INBX – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, analyst recommendations, risk, dividends and valuation. Analyst Recommendations This is a breakdown of recent […]

ITeos Therapeutics, Inc. (NASDAQ:ITOS – Free Report) – Equities research analysts at HC Wainwright boosted their FY2023 EPS estimates for iTeos Therapeutics in a research report issued to clients and investors on Wednesday, November 8th. HC Wainwright analyst S. Ramakanth now forecasts that the company will post earnings of ($3.84) per share for the year, […]

ITeos Therapeutics, Inc. (NASDAQ:ITOS – Get Free Report) insider Boxer Capital, Llc sold 350,000 shares of the company’s stock in a transaction dated Wednesday, August 23rd. The shares were sold at an average price of $16.26, for a total value of $5,691,000.00. Following the sale, the insider now owns 1,804,058 shares in the company, valued […]

ITeos Therapeutics (NASDAQ:ITOS – Get Free Report) and aTyr Pharma (NASDAQ:LIFE – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, valuation, dividends, profitability, risk and analyst recommendations. Institutional & Insider Ownership 71.9% of aTyr […]